Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Profit After Tax: 2012-2024

Historic Profit After Tax for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to -$193.5 million.

  • Ocular Therapeutix's Profit After Tax fell 90.22% to -$69.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$249.7 million, marking a year-over-year decrease of 43.21%. This contributed to the annual value of -$193.5 million for FY2024, which is 139.68% down from last year.
  • Ocular Therapeutix's Profit After Tax amounted to -$193.5 million in FY2024, which was down 139.68% from -$80.7 million recorded in FY2023.
  • Ocular Therapeutix's 5-year Profit After Tax high stood at -$6.6 million for FY2021, and its period low was -$193.5 million during FY2024.
  • For the 3-year period, Ocular Therapeutix's Profit After Tax averaged around -$115.1 million, with its median value being -$80.7 million (2023).
  • In the last 5 years, Ocular Therapeutix's Profit After Tax skyrocketed by 95.79% in 2021 and then crashed by 984.05% in 2022.
  • Over the past 5 years, Ocular Therapeutix's Profit After Tax (Yearly) stood at -$155.6 million in 2020, then surged by 95.79% to -$6.6 million in 2021, then plummeted by 984.05% to -$71.0 million in 2022, then dropped by 13.65% to -$80.7 million in 2023, then plummeted by 139.68% to -$193.5 million in 2024.